{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,23]],"date-time":"2026-08-23T16:39:13Z","timestamp":1787503153354,"version":"build-2736575974"},"reference-count":62,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2024,5,1]],"date-time":"2024-05-01T00:00:00Z","timestamp":1714521600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,5,1]],"date-time":"2024-05-01T00:00:00Z","timestamp":1714521600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2024,5,1]],"date-time":"2024-05-01T00:00:00Z","timestamp":1714521600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2024,5,1]],"date-time":"2024-05-01T00:00:00Z","timestamp":1714521600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2024,5,1]],"date-time":"2024-05-01T00:00:00Z","timestamp":1714521600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2024,5,1]],"date-time":"2024-05-01T00:00:00Z","timestamp":1714521600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2024,5,1]],"date-time":"2024-05-01T00:00:00Z","timestamp":1714521600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["International Journal of Biological Macromolecules"],"published-print":{"date-parts":[[2024,5]]},"DOI":"10.1016\/j.ijbiomac.2024.131739","type":"journal-article","created":{"date-parts":[[2024,4,22]],"date-time":"2024-04-22T11:11:33Z","timestamp":1713784293000},"page":"131739","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":22,"special_numbering":"P1","title":["Glucose-modified BSA\/procyanidin C1 NPs penetrate the blood-brain barrier and alleviate neuroinflammation in Alzheimer's disease models"],"prefix":"10.1016","volume":"268","author":[{"given":"Linyan","family":"Duan","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhizhong","family":"Hao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rong","family":"Ji","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xingfan","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hao","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yujing","family":"Su","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8415-0959","authenticated-orcid":false,"given":"Fangxia","family":"Guan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0780-4568","authenticated-orcid":false,"given":"Shanshan","family":"Ma","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"10284","key":"10.1016\/j.ijbiomac.2024.131739_bb0005","doi-asserted-by":"crossref","first-page":"1577","DOI":"10.1016\/S0140-6736(20)32205-4","article-title":"Alzheimer's disease","volume":"397","author":"Scheltens","year":"2021","journal-title":"Lancet"},{"issue":"4","key":"10.1016\/j.ijbiomac.2024.131739_bb0010","doi-asserted-by":"crossref","DOI":"10.1101\/cshperspect.a033118","article-title":"Clinical neurology and epidemiology of the major neurodegenerative diseases","volume":"10","author":"Erkkinen","year":"2018","journal-title":"Cold Spring Harb. Perspect. Biol."},{"issue":"1","key":"10.1016\/j.ijbiomac.2024.131739_bb0015","doi-asserted-by":"crossref","first-page":"289","DOI":"10.1016\/j.arr.2012.06.003","article-title":"Tau protein kinases: involvement in Alzheimer's disease","volume":"12","author":"Martin","year":"2013","journal-title":"Ageing Res. Rev."},{"key":"10.1016\/j.ijbiomac.2024.131739_bb0020","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejphar.2020.173554","article-title":"Alzheimer's disease: recent treatment strategies","volume":"887","author":"Vaz","year":"2020","journal-title":"Eur. J. Pharmacol."},{"issue":"1","key":"10.1016\/j.ijbiomac.2024.131739_bb0025","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1186\/s40035-022-00292-3","article-title":"Immunotherapy for Alzheimer's disease: targeting \u03b2-amyloid and beyond","volume":"11","author":"Song","year":"2022","journal-title":"Transl. Neurodegener."},{"key":"10.1016\/j.ijbiomac.2024.131739_bb0030","doi-asserted-by":"crossref","DOI":"10.1016\/j.arr.2022.101655","article-title":"The future of stem cell therapies of Alzheimer's disease","volume":"80","author":"Wang","year":"2022","journal-title":"Ageing Res. Rev."},{"key":"10.1016\/j.ijbiomac.2024.131739_bb0035","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejphar.2021.173974","article-title":"Role of natural products for the treatment of Alzheimer's disease","volume":"898","author":"Noori","year":"2021","journal-title":"Eur. J. Pharmacol."},{"issue":"9","key":"10.1016\/j.ijbiomac.2024.131739_bb0040","doi-asserted-by":"crossref","first-page":"2196","DOI":"10.3390\/polym15092196","article-title":"Nanoparticle-based drug delivery systems: an inspiring therapeutic strategy for neurodegenerative diseases","volume":"15","author":"Duan","year":"2023","journal-title":"Polymers"},{"issue":"8","key":"10.1016\/j.ijbiomac.2024.131739_bb0045","first-page":"953","article-title":"Exploration and expectation on treatment strategies of central nervous system diseases based on transporters at blood-brain barrier","volume":"25","author":"Zhong","year":"2020","journal-title":"Chin. J. Clin. Pharm. Th."},{"key":"10.1016\/j.ijbiomac.2024.131739_bb0050","doi-asserted-by":"crossref","DOI":"10.1016\/j.pharmthera.2022.108119","article-title":"Blood-brain barrier leakage in Alzheimer's disease: from discovery to clinical relevance","volume":"234","author":"Nehra","year":"2022","journal-title":"Pharmacol. Ther."},{"key":"10.1016\/j.ijbiomac.2024.131739_bb0055","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1016\/j.jff.2013.08.004","article-title":"Absorption and metabolism of proanthocyanidins","volume":"7","author":"Ou","year":"2014","journal-title":"J. Funct. Foods"},{"issue":"1","key":"10.1016\/j.ijbiomac.2024.131739_bb0060","doi-asserted-by":"crossref","first-page":"142","DOI":"10.3390\/ijms20010142","article-title":"Procyanidin C1 activates the Nrf2\/HO-1 signaling pathway to prevent glutamate-induced apoptotic HT22 cell death","volume":"20","author":"Song","year":"2019","journal-title":"Int. J. Mol. Sci."},{"issue":"1\u20133","key":"10.1016\/j.ijbiomac.2024.131739_bb0065","doi-asserted-by":"crossref","first-page":"218","DOI":"10.1016\/j.ejphar.2013.02.059","article-title":"The procyanidin trimer C1 induces macrophage activation via NF-kappaB and MAPK pathways, leading to Th1 polarization in murine splenocytes","volume":"714","author":"Sung","year":"2013","journal-title":"Eur. J. Pharmacol."},{"issue":"22","key":"10.1016\/j.ijbiomac.2024.131739_bb0070","doi-asserted-by":"crossref","first-page":"3267","DOI":"10.1080\/14786419.2018.1557173","article-title":"A comparative anticancer study on procyanidin C1 against receptor positive and receptor negative breast cancer","volume":"34","author":"Koteswari","year":"2020","journal-title":"Nat. Prod. Res."},{"issue":"12","key":"10.1016\/j.ijbiomac.2024.131739_bb0075","doi-asserted-by":"crossref","first-page":"1706","DOI":"10.1038\/s42255-021-00491-8","article-title":"The flavonoid procyanidin C1 has senotherapeutic activity and increases lifespan in mice","volume":"3","author":"Xu","year":"2021","journal-title":"Nat. Metab."},{"issue":"11","key":"10.1016\/j.ijbiomac.2024.131739_bb0080","doi-asserted-by":"crossref","first-page":"5159","DOI":"10.1002\/ptr.7975","article-title":"Flavonoids as promising anticancer therapeutics: contemporary research, nanoantioxidant potential, and future scope","volume":"37","author":"Gupta","year":"2023","journal-title":"Phytother. Res."},{"issue":"15","key":"10.1016\/j.ijbiomac.2024.131739_bb0085","doi-asserted-by":"crossref","first-page":"4109","DOI":"10.1039\/D0BM00809E","article-title":"Nanomaterial based drug delivery systems for the treatment of neurodegenerative diseases","volume":"8","author":"Masoudi Asil","year":"2020","journal-title":"Biomater Sci."},{"key":"10.1016\/j.ijbiomac.2024.131739_bb0090","doi-asserted-by":"crossref","first-page":"666","DOI":"10.1016\/j.biopha.2018.12.133","article-title":"Applications of nanotechnology in drug delivery to the central nervous system","volume":"111","author":"Saeedi","year":"2019","journal-title":"Biomed. Pharmacother."},{"issue":"1","key":"10.1016\/j.ijbiomac.2024.131739_bb0095","doi-asserted-by":"crossref","first-page":"108","DOI":"10.1602\/neurorx.2.1.108","article-title":"Drug transport to brain with targeted nanoparticles","volume":"2","author":"Olivier","year":"2005","journal-title":"NeuroRx"},{"issue":"3","key":"10.1016\/j.ijbiomac.2024.131739_bb0100","doi-asserted-by":"crossref","first-page":"457","DOI":"10.1002\/med.21252","article-title":"Medicinal chemistry based approaches and nanotechnology-based systems to improve CNS drug targeting and delivery","volume":"33","author":"Vlieghe","year":"2013","journal-title":"Med. Res. Rev."},{"issue":"1","key":"10.1016\/j.ijbiomac.2024.131739_bb0105","doi-asserted-by":"crossref","first-page":"180","DOI":"10.1186\/s12951-021-00925-1","article-title":"Integrin \u03b1<sub>2<\/sub>\u03b2<sub>1<\/sub>\u2212targeting ferritin nanocarrier traverses the blood-brain barrier for effective glioma chemotherapy","volume":"19","author":"Huang","year":"2021","journal-title":"J. Nanobiotechnol."},{"issue":"4","key":"10.1016\/j.ijbiomac.2024.131739_bb0110","doi-asserted-by":"crossref","first-page":"100","DOI":"10.31491\/APT.2022.12.100","article-title":"Evidence for an alternative insulin transporter at the blood-brain barrier","volume":"4","author":"Banks","year":"2022","journal-title":"Aging pathobiol. Ther."},{"issue":"21","key":"10.1016\/j.ijbiomac.2024.131739_bb0115","doi-asserted-by":"crossref","first-page":"8662","DOI":"10.1073\/pnas.1307152110","article-title":"Transcytosis and brain uptake of transferrin-containing nanoparticles by tuning avidity to transferrin receptor","volume":"110","author":"Wiley","year":"2013","journal-title":"Proc. Natl. Acad. Sci. USA"},{"issue":"41","key":"10.1016\/j.ijbiomac.2024.131739_bb0120","doi-asserted-by":"crossref","DOI":"10.1126\/sciadv.abc7031","article-title":"Blood-brain barrier-penetrating siRNA nanomedicine for Alzheimer's disease therapy","volume":"6","author":"Zhou","year":"2020","journal-title":"Sci. Adv."},{"issue":"4","key":"10.1016\/j.ijbiomac.2024.131739_bb0125","doi-asserted-by":"crossref","first-page":"3234","DOI":"10.1021\/acsnano.3c09715","article-title":"Mannose-integrated nanoparticle hitchhike glucose transporter 1 recycling to overcome various barriers of oral delivery for Alzheimer\u2019s disease therapy","volume":"18","author":"Lei","year":"2024","journal-title":"ACS Nano"},{"issue":"4","key":"10.1016\/j.ijbiomac.2024.131739_bb0130","doi-asserted-by":"crossref","first-page":"464","DOI":"10.1016\/0750-7658(96)83207-2","article-title":"Albumin metabolism","volume":"15","author":"Lefevre","year":"1996","journal-title":"Ann. Fr. D. Anesth. Reanim."},{"issue":"34","key":"10.1016\/j.ijbiomac.2024.131739_bb0135","doi-asserted-by":"crossref","first-page":"9940","DOI":"10.1002\/slct.201801648","article-title":"Development of an ionic liquid based method for the preparation of albumin nanoparticles","volume":"3","author":"Demirkurt","year":"2018","journal-title":"Chemistryselect"},{"issue":"Pt A","key":"10.1016\/j.ijbiomac.2024.131739_bb0140","doi-asserted-by":"crossref","first-page":"528","DOI":"10.1016\/j.ijbiomac.2021.10.040","article-title":"Anticancer nano-delivery systems based on bovine serum albumin nanoparticles: a critical review","volume":"193","author":"Solanki","year":"2021","journal-title":"Int. J. Biol. Macromol."},{"issue":"1","key":"10.1016\/j.ijbiomac.2024.131739_bb0145","doi-asserted-by":"crossref","first-page":"330","DOI":"10.1186\/s11671-018-2759-z","article-title":"Curcumin-loaded chitosan-bovine serum albumin nanoparticles potentially enhanced A\u03b242 phagocytosis and modulated macrophage polarization in Alzheimer's disease","volume":"13","author":"Yang","year":"2018","journal-title":"Nanoscale Res. Lett."},{"issue":"3","key":"10.1016\/j.ijbiomac.2024.131739_bb0150","doi-asserted-by":"crossref","DOI":"10.1002\/smll.201701828","article-title":"Detection of \u03b2-amyloid by sialic acid coated bovine serum albumin magnetic nanoparticles in a mouse model of Alzheimer's disease","volume":"14","author":"Nasr","year":"2018","journal-title":"Small"},{"key":"10.1016\/j.ijbiomac.2024.131739_bb0155","doi-asserted-by":"crossref","DOI":"10.1016\/j.foodchem.2020.127122","article-title":"Improving the functional properties of bovine serum albumin-glucose conjugates in natural deep eutectic solvents","volume":"328","author":"Fu","year":"2020","journal-title":"Food Chem."},{"issue":"4","key":"10.1016\/j.ijbiomac.2024.131739_bb0160","doi-asserted-by":"crossref","DOI":"10.1002\/adhm.202101808","article-title":"One-step synthesis of multifunctional chitosan hydrogel for full-thickness wound closure and healing","volume":"11","author":"Guo","year":"2022","journal-title":"Adv. Healthc. Mater."},{"key":"10.1016\/j.ijbiomac.2024.131739_bb0165","doi-asserted-by":"crossref","first-page":"759","DOI":"10.1016\/j.ijbiomac.2022.09.231","article-title":"Fucoidan ameliorates LPS-induced neuronal cell damage and cognitive impairment in mice","volume":"222","author":"Wang","year":"2022","journal-title":"Int. J. Biol. Macromol."},{"issue":"17","key":"10.1016\/j.ijbiomac.2024.131739_bb0170","doi-asserted-by":"crossref","first-page":"2590","DOI":"10.1021\/acschemneuro.0c00268","article-title":"MG53 protects hUC-MSCs against inflammatory damage and synergistically enhances their efficacy in neuroinflammation injured brain through inhibiting NLRP3\/Caspase-1\/IL-1\u03b2 axis","volume":"11","author":"Ma","year":"2020","journal-title":"ACS Chem. Neurosci."},{"issue":"27","key":"10.1016\/j.ijbiomac.2024.131739_bb0175","doi-asserted-by":"crossref","DOI":"10.1002\/adma.202201322","article-title":"Engineered nanoerythrocytes alleviate central nervous system inflammation by regulating the polarization of inflammatory microglia","volume":"34","author":"Yin","year":"2022","journal-title":"Adv. Mater."},{"key":"10.1016\/j.ijbiomac.2024.131739_bb0180","article-title":"MG53 attenuates lipopolysaccharide-induced neurotoxicity and neuroinflammation via inhibiting TLR4\/NF-\u03baB pathway in vitro and in vivo","volume":"95","author":"Guan","year":"2019","journal-title":"Prog. Neurobiol."},{"issue":"1","key":"10.1016\/j.ijbiomac.2024.131739_bb0185","doi-asserted-by":"crossref","first-page":"352","DOI":"10.1186\/s13287-019-1433-4","article-title":"The TRIM protein mitsugumin 53 enhances survival and therapeutic efficacy of stem cells in murine traumatic brain injury","volume":"10","author":"Guan","year":"2019","journal-title":"Stem Cell Res Ther"},{"key":"10.1016\/j.ijbiomac.2024.131739_bb0190","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1016\/j.cis.2017.06.012","article-title":"Impact of albumin based approaches in nanomedicine: imaging, targeting and drug delivery","volume":"246","author":"Bhushan","year":"2017","journal-title":"Adv. Colloid Interf. Sci."},{"key":"10.1016\/j.ijbiomac.2024.131739_bb0195","doi-asserted-by":"crossref","DOI":"10.1016\/j.foodchem.2020.126341","article-title":"Characteristics and antioxidant activity of maillard reaction products from \u03b1-lactalbumin and 2\u2032-fucosyllactose","volume":"316","author":"Tu","year":"2020","journal-title":"Food Chem."},{"issue":"2","key":"10.1016\/j.ijbiomac.2024.131739_bb0200","doi-asserted-by":"crossref","first-page":"286","DOI":"10.1002\/(SICI)1097-4636(199802)39:2<286::AID-JBM16>3.0.CO;2-B","article-title":"False positive results in cytotoxicity testing due to unexpectedly volatile compounds","volume":"39","author":"Ciapetti","year":"1998","journal-title":"J. Biomed. Mater. Res."},{"issue":"6","key":"10.1016\/j.ijbiomac.2024.131739_bb0205","doi-asserted-by":"crossref","first-page":"1481","DOI":"10.7150\/thno.21254","article-title":"Current strategies for brain drug delivery","volume":"8","author":"Dong","year":"2018","journal-title":"Theranostics"},{"issue":"1","key":"10.1016\/j.ijbiomac.2024.131739_bb0210","doi-asserted-by":"crossref","first-page":"2488","DOI":"10.1038\/s41467-020-16191-y","article-title":"Neutrophil extracellular traps released by neutrophils impair revascularization and vascular remodeling after stroke","volume":"11","author":"Kang","year":"2020","journal-title":"Nat. Commun."},{"issue":"12","key":"10.1016\/j.ijbiomac.2024.131739_bb0215","first-page":"1063","article-title":"Aldo-keto reductase 1 member B1 (AKR1B1) inhibits retinal ganglion cell activity via activating NF-kappaB pathway and inducing mouse BV-2 microglia activation","volume":"36","author":"Bai","year":"2020","journal-title":"Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi"},{"issue":"9","key":"10.1016\/j.ijbiomac.2024.131739_bb0220","doi-asserted-by":"crossref","first-page":"2491","DOI":"10.1007\/s00204-019-02538-y","article-title":"Management of oxidative stress and other pathologies in Alzheimer's disease","volume":"93","author":"Simunkova","year":"2019","journal-title":"Arch. Toxicol."},{"issue":"1","key":"10.1016\/j.ijbiomac.2024.131739_bb0225","doi-asserted-by":"crossref","first-page":"4","DOI":"10.1186\/s40035-022-00279-0","article-title":"Brain-derived neurotrophic factor in Alzheimer's disease and its pharmaceutical potential","volume":"11","author":"Gao","year":"2022","journal-title":"Transl. Neurodegener."},{"key":"10.1016\/j.ijbiomac.2024.131739_bb0230","doi-asserted-by":"crossref","DOI":"10.1016\/j.jep.2023.116306","article-title":"Network pharmacology, a promising approach to reveal the pharmacology mechanism of Chinese medicine formula","volume":"309","author":"Zhao","year":"2023","journal-title":"J. Ethnopharmacol."},{"issue":"1","key":"10.1016\/j.ijbiomac.2024.131739_bb0235","doi-asserted-by":"crossref","first-page":"380","DOI":"10.1186\/s12967-023-04233-0","article-title":"Uncovering the mechanism of resveratrol in the treatment of diabetic kidney disease based on network pharmacology, molecular docking, and experimental validation","volume":"21","author":"Chen","year":"2023","journal-title":"J. Transl. Med."},{"issue":"9","key":"10.1016\/j.ijbiomac.2024.131739_bb0240","doi-asserted-by":"crossref","first-page":"2114","DOI":"10.1038\/s41423-021-00740-6","article-title":"NLRP3 inflammasome activation and cell death","volume":"18","author":"Huang","year":"2021","journal-title":"Cell. Mol. Immunol."},{"issue":"2","key":"10.1016\/j.ijbiomac.2024.131739_bb0245","doi-asserted-by":"crossref","first-page":"177","DOI":"10.4155\/tde.14.97","article-title":"Nanotherapeutic strategies for the treatment of Alzheimer's disease","volume":"6","author":"Gu","year":"2015","journal-title":"Ther. Deliv."},{"issue":"25","key":"10.1016\/j.ijbiomac.2024.131739_bb0250","doi-asserted-by":"crossref","DOI":"10.1002\/smll.201801588","article-title":"Drug delivery to the brain across the blood-brain barrier using nanomaterials (vol 13, 1701921, 2017)","volume":"14","author":"Tsou","year":"2018","journal-title":"Small"},{"issue":"10","key":"10.1016\/j.ijbiomac.2024.131739_bb0255","doi-asserted-by":"crossref","first-page":"937","DOI":"10.1016\/j.tibtech.2017.06.002","article-title":"Advances in Alzheimer's diagnosis and therapy: the implications of nanotechnology","volume":"35","author":"Hajipour","year":"2017","journal-title":"Trends Biotechnol."},{"issue":"10","key":"10.1016\/j.ijbiomac.2024.131739_bb0260","doi-asserted-by":"crossref","first-page":"2893","DOI":"10.3390\/cancers12102893","article-title":"Advances in natural or synthetic nanoparticles for metastatic melanoma therapy and diagnosis","volume":"12","author":"Arasi","year":"2020","journal-title":"Cancers (Basel)"},{"issue":"3","key":"10.1016\/j.ijbiomac.2024.131739_bb0265","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1038\/nrneurol.2017.188","article-title":"Blood-brain barrier breakdown in Alzheimer disease and other neurodegenerative disorders","volume":"14","author":"Sweeney","year":"2018","journal-title":"Nat. Rev. Neurol."},{"key":"10.1016\/j.ijbiomac.2024.131739_bb0270","doi-asserted-by":"crossref","DOI":"10.3389\/fncel.2021.638686","article-title":"Inflammation spreading: negative spiral linking systemic inflammatory disorders and Alzheimer's disease","volume":"15","author":"Ni","year":"2021","journal-title":"Front. Cell. Neurosci."},{"issue":"5580","key":"10.1016\/j.ijbiomac.2024.131739_bb0275","doi-asserted-by":"crossref","first-page":"353","DOI":"10.1126\/science.1072994","article-title":"The amyloid hypothesis of Alzheimer's disease: progress and problems on the road to therapeutics","volume":"297","author":"Hardy","year":"2002","journal-title":"Science"},{"issue":"1","key":"10.1016\/j.ijbiomac.2024.131739_bb0280","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1038\/s41583-019-0240-3","article-title":"Amyloid-\u03b2-independent regulators of tau pathology in Alzheimer disease","volume":"21","author":"van der Kant","year":"2020","journal-title":"Nat. Rev. Neurosci."},{"key":"10.1016\/j.ijbiomac.2024.131739_bb0285","doi-asserted-by":"crossref","first-page":"112","DOI":"10.1016\/j.semcdb.2019.05.004","article-title":"Microglia-mediated neuroinflammation in neurodegenerative diseases","volume":"94","author":"Subhramanyam","year":"2019","journal-title":"Semin. Cell Dev. Biol."},{"issue":"2","key":"10.1016\/j.ijbiomac.2024.131739_bb0290","doi-asserted-by":"crossref","first-page":"450","DOI":"10.1016\/j.intimp.2012.11.021","article-title":"The procyanidin trimer C1 inhibits LPS-induced MAPK and NF-kappa B signaling through TLR4 in macrophages","volume":"15","author":"Byun","year":"2013","journal-title":"Int. Immunopharmacol."},{"key":"10.1016\/j.ijbiomac.2024.131739_bb0295","doi-asserted-by":"crossref","DOI":"10.3389\/fphar.2021.648636","article-title":"PI3K\/AKT signal pathway: a target of natural products in the prevention and treatment of Alzheimer's disease and Parkinson's disease","volume":"12","author":"Long","year":"2021","journal-title":"Front. Pharmacol."},{"issue":"7","key":"10.1016\/j.ijbiomac.2024.131739_bb0300","doi-asserted-by":"crossref","first-page":"1133","DOI":"10.1007\/s10571-020-00801-w","article-title":"Neuroprotective effects of salidroside in a mouse model of Alzheimer's disease","volume":"40","author":"Wang","year":"2020","journal-title":"Cell. Mol. Neurobiol."},{"key":"10.1016\/j.ijbiomac.2024.131739_bb0305","doi-asserted-by":"crossref","first-page":"349","DOI":"10.1016\/j.ijbiomac.2020.02.282","article-title":"Astragalus polysaccharide exerts anti-Parkinson via activating the PI3K\/AKT\/mTOR pathway to increase cellular autophagy level in vitro","volume":"153","author":"Tan","year":"2020","journal-title":"Int. J. Biol. Macromol."},{"key":"10.1016\/j.ijbiomac.2024.131739_bb0310","doi-asserted-by":"crossref","first-page":"50","DOI":"10.3389\/fimmu.2013.00050","article-title":"Mechanisms of disease: inflammasome activation and the development of type 2 diabetes","volume":"4","author":"Grant","year":"2013","journal-title":"Front. Immunol."}],"container-title":["International Journal of Biological Macromolecules"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0141813024025443?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0141813024025443?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2024,9,23]],"date-time":"2024-09-23T18:32:25Z","timestamp":1727116345000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0141813024025443"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,5]]},"references-count":62,"alternative-id":["S0141813024025443"],"URL":"https:\/\/doi.org\/10.1016\/j.ijbiomac.2024.131739","relation":{},"ISSN":["0141-8130"],"issn-type":[{"value":"0141-8130","type":"print"}],"subject":[],"published":{"date-parts":[[2024,5]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Glucose-modified BSA\/procyanidin C1 NPs penetrate the blood-brain barrier and alleviate neuroinflammation in Alzheimer's disease models","name":"articletitle","label":"Article Title"},{"value":"International Journal of Biological Macromolecules","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ijbiomac.2024.131739","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 Elsevier B.V. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"131739"}}